Peishan Li
Overview
Explore the profile of Peishan Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue P, Lin L, Li P, Cheng S, Chen D, Fan M, et al.
BMC Public Health
. 2025 Mar;
25(1):985.
PMID: 40075403
Background: The findings of the 2021 Global Burden of Disease (GBD) study can offer valuable insights for the development of screening and prevention strategies targeting ischemic heart disease (IHD). We...
2.
Liu X, Sun X, Mu W, Li Y, Bu W, Yang T, et al.
Cell Death Discov
. 2025 Jan;
11(1):21.
PMID: 39856069
Cancer development is associated with adaptation to various stressful conditions, such as extracellular acidosis. The adverse tumor microenvironment also selects for increased malignancy. Mitochondria are integral in stress sensing to...
3.
Wang Z, Wang X, Li P, Xia H, Yang X
Neurol Res
. 2025 Jan;
47(2):129-138.
PMID: 39743746
Background: Immune dysregulation is commonly associated with neurodegenerative diseases (NDs), yet the underlying causes and mechanisms still require further investigation. Objective: This study investigates the correlation between immune-related plasma proteins...
4.
Wang Z, Zhang Z, Li P, Cao Q, Fan P, Xia H, et al.
Sci Rep
. 2024 Dec;
14(1):31167.
PMID: 39730760
Parkinson's disease (PD) is the second most common age-related neurodegenerative disease after Alzheimer's disease. Despite numerous studies, specific age-related factors remain unidentified. This study employed a multi-omics approach to investigate...
5.
Bai C, Zhang L, Gao L, Peng L, Li P, Yang L
Front Plant Sci
. 2024 Dec;
15:1475282.
PMID: 39711594
Introduction: The assessment of the severity of fruit disease is crucial for the optimization of fruit production. By quantifying the percentage of leaf disease, an effective approach to determining the...
6.
Zhang X, Zhao Y, Jiang L, Hu Y, Liu Z, Xu Q, et al.
Parkinsonism Relat Disord
. 2024 Nov;
130:107212.
PMID: 39581168
Introduction: Glucosylceramidase beta 1 (GBA1) mutations are a genetic risk factor for Parkinson's disease (PD), though most carriers do not develop the disease. This study aimed to identify exposure factors...
7.
Liu Y, Li P, Liao J, Rao M, Peng L, Gan H, et al.
Med Sci Monit
. 2024 Nov;
30:e945848.
PMID: 39568191
BACKGROUND This study aimed to investigate the expression of RSPO3 and ß-catenin in preeclampsia and the relationship between RSPO3 and b-catenin levels and maternal-fetal outcomes. MATERIAL AND METHODS We enrolled...
8.
Li P, Li J, Cheng J, Huang J, Li J, Xiao J, et al.
J Control Release
. 2024 Nov;
377:277-287.
PMID: 39561946
Liposomes, especially polyethylene glycol (PEG)-modified long-circulating liposomes, have been approved for market use, due to good biocompatibility, passive tumor targeting, and sustained drug release. PEG-modified long-circulating liposomes address issues such...
9.
Ren Y, Li P, Xie Y, Xu J, Luo Q, Chen M, et al.
J Control Release
. 2024 Nov;
377:146-161.
PMID: 39549730
Drug delivery efficiency often affects chemotherapy outcome due to dense collagen barrier in tumor environment. Here, we report a nanoparticle capable of pH and glutathione dual-responsive drug delivery to enhance...
10.
Hu Q, Wang Z, Li J, Cao W, Li P, Xie X, et al.
Anal Chem
. 2024 Oct;
96(43):17353-17361.
PMID: 39418228
Cell membrane-coated nanoparticles (CNPs) have emerged as an attractive nanomedical tool. The basic premise is that the surface properties of natural cells can be integrated with the physical and chemical...